IDENTIFICATION OF BIOMARKERS OF EXPOSURE AND EFFECT OF 1,4-DICHLOROHEXAFLUOROBUTENE-2

Cover Page

Cite item

Full Text

Abstract

Using gas and high-performance liquid chromatography with mass-selective detection (GC/MS and HPLC/MS, respectively), the metabolism of previously unstudied freon RL316 (1,4-dichloro-1,1,2,3,4,4-hexafluorobutene-2, hereinafter - DCHF) has been investigated. Two volatile metabolites, which are products of reductive replacement of chlorine atoms: 1-chloro-1,1,2,3,3,4,4,4-octafluorobutane and 1-chloro-1,1,2,3,4,4-hexafluorobutene-2, have been detected and identified in the blood and urine samples of rats. In total 15 different previously unknown metabolites have been revealed and identified. The main direction of metabolism of DCHF is the formation of adducts with glutathione and their further degradation to cysteine and acetylcysteine adducts. Among all metabolites 4-methylsulfyl-1-chloro-1,1,2,3,4,4-hexafluorobutene-2, 4-methylsulfynyl-1-chloro-1,1,2,3,4,4-hexafluorobutene-2 and 1,1,3,4,4-pentafluoro-1,4-dichlorobutanethion-2 were found to be the most sensitive biomarkers. The intake of DCHF in the body does not lead to its bioactivation with the formation of labile thioketenes which are the main cause of mutagenic and carcinogenic effects of some halocarbons.

Metabolic profiling of blood plasma revealed potential metabolic markers of exposure to D CHF at a concentration of 18,8 mg/m3: the ratio of concentrations of gulonic acid and myo-inositol phosphate. The combination of the determination of the chemical markers - nonmetabolic forms of DCHF and 1,4-dichloro-1,1,3,4,4-butanthione-2 with the definition of discovered metabolic markers allows to estimate more accurately the dose or level of exposure of DCHF on the body of people in contact with it.

About the authors

A. I. Ukolov

Research Institute of Hygiene, Occupational Pathology and Human Ecology, Federal Medical and Biological Agency

Author for correspondence.
Email: AntonUkolov@gmail.com

Ukolov Anton Igorevich

188663, Leningrad region, Kuzmolovsky

Russian Federation

M. D. Shachneva

Research Institute of Hygiene, Occupational Pathology and Human Ecology, Federal Medical and Biological Agency

Email: shachneva_mariya@mail.ru

Shachneva Maria Dmitrievna

188663, Leningrad region, Kuzmolovsky

Russian Federation

A. S. Radilov

Research Institute of Hygiene, Occupational Pathology and Human Ecology, Federal Medical and Biological Agency

Email: radilov@rihophe.ru

Radilov Andrey Stanislavovich

188663, Leningrad region, Kuzmolovsky

Russian Federation

References

  1. Materials on the experimental substantiation of the approximate safe exposure level of 1,4-dichlorohexafluorobutene-2 (RL316) in the air of the working area. FSUE RIHOPHE FMBA of Russia , prof. Radilov A.S. Saint-Petersburg, 2015 (in Russian).
  2. TruhautR., Boudene C., JouanyJ.M., Bouant A. Experimental study of the toxicity of a fluoroalkene derivative, the hexafluorodichlorobutene (HFCB). Fluoride. 1972; 5; 1: 4-14.
  3. Corrigan D.S., McHattie G.Y., Reventos J. Halothane and Dichlorohexafluorobutene. Brit. J. Anesthesia. 1963; 35: 824-825.
  4. Grushko Ya.M. Harmful organic compounds in industrial emissions. Leningrad: Khimiya. 1986.143 p. (in Russian).
  5. Muravieva S.I., Kaznina N.I., Prokhorova E.K. Handbook for the control of harmful substances in the air. Moscow: Khimiya. 1988.-143 p. (in Russian).
  6. FilovV.A. Harmful chemicals. Hydrocarbons, halogen derivatives of hydrocarbons: a handbook. Leningrad: Khimiya. 1990.-732 p. (in Russian).
  7. Lazarev N.V. Harmful chemicals. Organic compounds: Handbook. Leningrad: Khimiya. 1976; V.1.- 300 p. (in Russian).
  8. Hayden P.J., Hayden P.J., Stevens J.L. Cysteine conjugate toxicity, metabolism, and binding to macromolecules in isolated rat kidney mitochondria. Mol. Pharm. 1990; 37: 468-476.
  9. Ukolov A.I., Orlova T.I., Migalovskaya E.D., Voitenko N.G., Goncharov N.V. Metabolomics: On the Way to an Integration of Biochemistry, Analytical Chemistry, and Informatics. Biol. Bulletin Reviews. 2015; 135; 1: 3-17.
  10. Ukolov, A.I., Kessenikh, E.D., Radilov, A.S., Goncharov N.V. Toxicometabolomics: Identification of markers of chronic exposure to low doses of aliphatic hydrocarbons. J. Evol. Biochem. Phys. 2017; 53; 1: 24-32. (in Russian)
  11. Orlova T.I., Ukolov A.I., Savelieva E.I., Radilov A.S. GC-MS quantification of free and es-terified fatty acids in blood plasma. Analitika i kontrol. 2015; 19(2): 183 (in Russian).
  12. Ukolov A.I., Orlova T.I., Savelieva E.I., Radilov A.S. Chromatographic-Mass Spectrometric Determination of Free Fatty Acids in Blood Plasma and Urine Using Extractive Alkylation. J. of Anal. Chemistry. 2015; 70(9): 968. (in Russian).
  13. Dekant W. Toxicology of Chlorofluorocarbon Replacements. Environ. Health Perspect. 1996; 104; 1: 75-83.
  14. Anders M.W. Metabolism and Toxicity of Hydrochlorofluorocarbons: Current Knowledge and Needs for the Future. Environ. Health Perspect. 1991; 96: 185-191.
  15. Dekant W., Vamvakas S., Berthold K., Schmidt S., Wild D., Henschler D. Bacterial-lyase mediated cleavage and mutagenicity of cysteine conjugates derived from the nephrocarcinogenic alkenes trichloroethylene, tetrachloroethylene and hexachlorobutadiene. Chem.-Biol. Interact. 1986; 60: 31-45.
  16. Anders M.W., Lash L., Dekant W., Elfarra A.A., Dohn D.R. Biosynthesis and bioansformation of glutathione S-conjugates to toxic metabolites. CRC Crit. Rev. Toxicol. 1988; 18: 311-341.
  17. Dreehen B., Westphal G. Mutagenicity of the glutathione and cysteine S-conjugates of the haloalkenes 1,1,2-trichloro-3,3,3-trifluoro-1-propene and trichlorofluoroethene in the Ames test in comparison with the tetrachloroethene-analogues. Mut. Res. 2003; 539: 157-166.
  18. Lock E.A., Berndt W.O. Studies on the Mechanism of Nephrotoxicity and Nephrocarcinogenicity of Halogenated Alkenes. CRC Crit. Rev. Toxicol. 1988; 19; 1: 23-42.
  19. MacNichol D.D., Robertson D.D. New and unexpected reactivity of saturated fluorocarbons. Nature. 1988; 332: 59-61.
  20. Wkelman C., Kazis C. Recent advances in the chemistry ofhalogenofluorocabons. J. FluorineChem. 1986; 33: 347-359.
  21. Blair I.A. Analysis of endogenous glutathione-adducts and their metabolites. Biomed. Chromatogr. 2010; 24; 1: P. 29-38.
  22. Blair I.A. Endogenous glutathione adducts. Curr. Drug Metab. 2006; 7; 8: 853-872.
  23. Awasthi Y.C., Sharma R., Yadav S., Dwivedi S., Sharma A., Awasthi S. The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistance. Curr. Drug Metab. 2007; 8; 4: 315-323.
  24. Green T., Lee R., Farrar D., Hill J. Assessing the health risks following environmental exposure to hexachlorobutadiene. Toxicol Lett. 2003; 138; 1-2: 63-73.
  25. Poet T.S., Wu H., Corley R.A., Thrall K.D. In vitro glutathione conjugation of methyl iodide in rat, rabbit, and human blood and tissues. Inhal. Toxicol. - 2009. - V. 21. - N. 6. - P. 524-530.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Ukolov A.I., Shachneva M.D., Radilov A.S.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 81728 от 11 декабря 2013.